Public health safety and transplant with increased-risk organs

Striking the balance

Ramesh Batra, Nitin Katariya, Winston Hewitt, Amit Mathur, Kunam Sudhakar Reddy, Adyr Moss, Dorry Segev, Andrew Singer

Research output: Contribution to journalArticle

Abstract

There is significant variability amongst transplant centers, Organ Procurement Organizations (OPO), members of public, and patients about organs from Public Health Service increased risk donors. This has therefore required regulatory bodies like Centers for Disease Control and Prevention to formulate policies for transplant centers and OPOs to minimize risk of infectious transmission to recipients of solid-organ transplants from such donors.

Original languageEnglish (US)
Pages (from-to)9-12
Number of pages4
JournalExperimental and Clinical Transplantation
Volume13
DOIs
StatePublished - Jul 23 2015

Fingerprint

Public Health
Transplants
Safety
Tissue Donors
Tissue and Organ Procurement
United States Public Health Service
Centers for Disease Control and Prevention (U.S.)
Organizations

Keywords

  • Antibody test
  • Hepatitis B virus
  • Hepatitis C virus
  • Human immunodeficiency virus
  • Nucleic acid test
  • Outcomes
  • Survival

ASJC Scopus subject areas

  • Transplantation

Cite this

Public health safety and transplant with increased-risk organs : Striking the balance. / Batra, Ramesh; Katariya, Nitin; Hewitt, Winston; Mathur, Amit; Reddy, Kunam Sudhakar; Moss, Adyr; Segev, Dorry; Singer, Andrew.

In: Experimental and Clinical Transplantation, Vol. 13, 23.07.2015, p. 9-12.

Research output: Contribution to journalArticle

Batra, Ramesh ; Katariya, Nitin ; Hewitt, Winston ; Mathur, Amit ; Reddy, Kunam Sudhakar ; Moss, Adyr ; Segev, Dorry ; Singer, Andrew. / Public health safety and transplant with increased-risk organs : Striking the balance. In: Experimental and Clinical Transplantation. 2015 ; Vol. 13. pp. 9-12.
@article{0086211b81194b5f9788569f874185cb,
title = "Public health safety and transplant with increased-risk organs: Striking the balance",
abstract = "There is significant variability amongst transplant centers, Organ Procurement Organizations (OPO), members of public, and patients about organs from Public Health Service increased risk donors. This has therefore required regulatory bodies like Centers for Disease Control and Prevention to formulate policies for transplant centers and OPOs to minimize risk of infectious transmission to recipients of solid-organ transplants from such donors.",
keywords = "Antibody test, Hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus, Nucleic acid test, Outcomes, Survival",
author = "Ramesh Batra and Nitin Katariya and Winston Hewitt and Amit Mathur and Reddy, {Kunam Sudhakar} and Adyr Moss and Dorry Segev and Andrew Singer",
year = "2015",
month = "7",
day = "23",
doi = "10.6002/ect.mesot2014.L12",
language = "English (US)",
volume = "13",
pages = "9--12",
journal = "Experimental and Clinical Transplantation",
issn = "1304-0855",
publisher = "Baskent University",

}

TY - JOUR

T1 - Public health safety and transplant with increased-risk organs

T2 - Striking the balance

AU - Batra, Ramesh

AU - Katariya, Nitin

AU - Hewitt, Winston

AU - Mathur, Amit

AU - Reddy, Kunam Sudhakar

AU - Moss, Adyr

AU - Segev, Dorry

AU - Singer, Andrew

PY - 2015/7/23

Y1 - 2015/7/23

N2 - There is significant variability amongst transplant centers, Organ Procurement Organizations (OPO), members of public, and patients about organs from Public Health Service increased risk donors. This has therefore required regulatory bodies like Centers for Disease Control and Prevention to formulate policies for transplant centers and OPOs to minimize risk of infectious transmission to recipients of solid-organ transplants from such donors.

AB - There is significant variability amongst transplant centers, Organ Procurement Organizations (OPO), members of public, and patients about organs from Public Health Service increased risk donors. This has therefore required regulatory bodies like Centers for Disease Control and Prevention to formulate policies for transplant centers and OPOs to minimize risk of infectious transmission to recipients of solid-organ transplants from such donors.

KW - Antibody test

KW - Hepatitis B virus

KW - Hepatitis C virus

KW - Human immunodeficiency virus

KW - Nucleic acid test

KW - Outcomes

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=84939815347&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939815347&partnerID=8YFLogxK

U2 - 10.6002/ect.mesot2014.L12

DO - 10.6002/ect.mesot2014.L12

M3 - Article

VL - 13

SP - 9

EP - 12

JO - Experimental and Clinical Transplantation

JF - Experimental and Clinical Transplantation

SN - 1304-0855

ER -